Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 13.98
+0.79 (5.99%)
Aug 4, 2026, 3:00 PM CST
SHA:688488 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,883 | 6,871 | 3,307 | 5,264 | 4,427 | 6,539 | |
Market Cap Growth | -12.57% | 107.76% | -37.17% | 18.91% | -32.31% | -37.22% |
Enterprise Value | 6,184 | 7,039 | 3,402 | 5,147 | 4,084 | 5,910 |
Last Close Price | 13.98 | 16.33 | 7.86 | 12.51 | 10.54 | 15.57 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 145.16 | - | - | - | - |
PS Ratio | 8.41 | 9.56 | 7.92 | 12.80 | 18.13 | 25.57 |
PB Ratio | 5.40 | 6.40 | 3.10 | 4.68 | 3.69 | 4.99 |
P/TBV Ratio | 9.01 | 10.76 | 5.22 | 5.28 | 4.14 | 5.60 |
P/OCF Ratio | - | 389.72 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.84 | 9.79 | 8.14 | 12.51 | 16.72 | 23.11 |
EV/EBITDA Ratio | 72.11 | 80.80 | - | - | - | - |
EV/EBIT Ratio | 209.37 | 202.47 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.66 | 0.52 | 0.46 | 0.37 | 0.17 | 0.00 |
Debt / EBITDA Ratio | 8.40 | 6.22 | - | - | - | - |
Net Debt / Equity Ratio | 0.17 | 0.10 | 0.04 | -0.03 | -0.23 | -0.46 |
Net Debt / EBITDA Ratio | 2.24 | 1.24 | -0.49 | 0.45 | 2.01 | 17.11 |
Net Debt / FCF Ratio | -2.80 | -3.56 | -0.57 | 0.12 | 1.19 | 5.60 |
Asset Turnover | 0.35 | 0.38 | 0.23 | 0.24 | 0.16 | 0.18 |
Inventory Turnover | 0.90 | 1.00 | 1.02 | 1.44 | 1.27 | 1.79 |
Quick Ratio | 1.10 | 0.92 | 0.93 | 1.32 | 1.87 | 7.52 |
Current Ratio | 1.50 | 1.32 | 1.38 | 1.78 | 2.42 | 8.94 |
Return on Equity (ROE) | -0.31% | 0.76% | -12.66% | -6.54% | -9.89% | -2.25% |
Return on Assets (ROA) | 0.93% | 1.15% | -4.91% | -3.90% | -6.94% | -2.70% |
Return on Invested Capital (ROIC) | -0.90% | 0.99% | -12.86% | -10.51% | -21.05% | -9.68% |
Return on Capital Employed (ROCE) | 2.10% | 2.90% | -11.60% | -8.40% | -13.00% | -4.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.47% | -0.28% | -4.27% | -1.44% | -2.80% | -0.46% |
FCF Yield | -1.13% | -0.44% | -2.48% | -4.51% | -5.26% | -1.64% |
Buyback Yield / Dilution | -4.84% | -1.36% | 1.73% | -2.17% | 3.44% | -7.71% |
Total Shareholder Return | -4.84% | -1.36% | 1.73% | -2.17% | 3.44% | -7.71% |